Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Offsetting Hippocampal Degeneration in Moderate to Severe TBI

NCT03727334 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT03727334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03727334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Offsetting Hippocampal Degeneration in Moderate to Severe TBI
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Unknown status
Start date
July 25, 2019
Completion date
July 31, 2024
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degeneration, memory; loss, mild, following organic brain damage, traumatic brain injury